602 related articles for article (PubMed ID: 26003861)
1. Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.
Mandal PK; Saharan S; Tripathi M; Murari G
Biol Psychiatry; 2015 Nov; 78(10):702-10. PubMed ID: 26003861
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease: An in vivo MRS Study.
Shukla D; Mandal PK; Mishra R; Punjabi K; Dwivedi D; Tripathi M; Badhautia V
J Alzheimers Dis; 2021; 84(3):1139-1152. PubMed ID: 34633325
[TBL] [Abstract][Full Text] [Related]
4. Brain oxidative stress: detection and mapping of anti-oxidant marker 'Glutathione' in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy.
Mandal PK; Tripathi M; Sugunan S
Biochem Biophys Res Commun; 2012 Jan; 417(1):43-8. PubMed ID: 22120629
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of in vivo brain glutathione conformers in cingulate cortex among age-matched control, MCI, and AD patients using MEGA-PRESS.
Shukla D; Mandal PK; Tripathi M; Vishwakarma G; Mishra R; Sandal K
Hum Brain Mapp; 2020 Jan; 41(1):194-217. PubMed ID: 31584232
[TBL] [Abstract][Full Text] [Related]
6. Altered central and blood glutathione in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
Chen JJ; Thiyagarajah M; Song J; Chen C; Herrmann N; Gallagher D; Rapoport MJ; Black SE; Ramirez J; Andreazza AC; Oh P; Marzolini S; Graham SJ; Lanctôt KL
Alzheimers Res Ther; 2022 Feb; 14(1):23. PubMed ID: 35123548
[TBL] [Abstract][Full Text] [Related]
7. Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment.
Zhu X; Cao L; Hu X; Dong Y; Wang H; Liu F; Sun Z
Clin Neurol Neurosurg; 2015 Mar; 130():80-5. PubMed ID: 25590663
[TBL] [Abstract][Full Text] [Related]
8. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
Dukart J; Sambataro F; Bertolino A
J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054
[TBL] [Abstract][Full Text] [Related]
9. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
[TBL] [Abstract][Full Text] [Related]
11. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
[TBL] [Abstract][Full Text] [Related]
12. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.
Han P; Caselli RJ; Baxter L; Serrano G; Yin J; Beach TG; Reiman EM; Shi J
JAMA Neurol; 2015 Mar; 72(3):333-9. PubMed ID: 25599520
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
14. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
[TBL] [Abstract][Full Text] [Related]
15. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
[TBL] [Abstract][Full Text] [Related]
16. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
[TBL] [Abstract][Full Text] [Related]
17. Cognitive Improvement with Glutathione Supplement in Alzheimer's Disease: A Way Forward.
Mandal PK; Shukla D; Tripathi M; Ersland L
J Alzheimers Dis; 2019; 68(2):531-535. PubMed ID: 30776003
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
[TBL] [Abstract][Full Text] [Related]
19. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).
Ellis KA; Szoeke C; Bush AI; Darby D; Graham PL; Lautenschlager NT; Macaulay SL; Martins RN; Maruff P; Masters CL; McBride SJ; Pike KE; Rainey-Smith SR; Rembach A; Robertson J; Rowe CC; Savage G; Villemagne VL; Woodward M; Wilson W; Zhang P; Ames D;
Int Psychogeriatr; 2014 Apr; 26(4):543-54. PubMed ID: 24252258
[TBL] [Abstract][Full Text] [Related]
20. Glutathione relates to neuropsychological functioning in mild cognitive impairment.
Duffy SL; Lagopoulos J; Hickie IB; Diamond K; Graeber MB; Lewis SJ; Naismith SL
Alzheimers Dement; 2014 Jan; 10(1):67-75. PubMed ID: 23688577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
